Showing results 1 to 20 of 55
next >
| Issue Date | Title | Author(s) |
| 2009 | Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach | Raftery, J; Hanney, S; Green, C; Buxton, MJ |
| 2008 | Assessing the impact of health technology assessment in the Netherlands | Oortwijn, WJ; Hanney, S; Ligtvoet, A; Hoorens, S; Wooding, S; Grant, J; Buxton, MJ; Bouter, LM |
| 2010 | Assessing the payback from health R & D: From ad hoc studies to regular monitoring | Buxton, MJ; Croxson, B; Hanney, S |
| 2008 | Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial | Dyer, MT; Goldsmith, KA; Khan, SN; Sharples, LD; Freeman, C; Hardy, I; Buxton, MJ; Schofield, MP |
| 1992 | Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis | O'Brien, BJ; Buxton, MJ; Rusby, RA |
| 1989 | Cost minimisation study of transdermal glyceryl trinitrate in reducing failures of peripheral intravenous infusion | Khawaja, HT; O'Brien, BJ; Buxton, MJ; Weaver, PC |
| 11-Oct-2012 | Cost-effectiveness of a European preventive cardiology programme in primary care: A Markov modelling approach | Mistry, H; Morris, S; Kotseva, K; Wood, D; Buxton, MJ |
| 2008 | The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial | Henriksson, M; Epstein, DM; Palmer, SJ; Sculpher, MJ; Clayton, TC; Pocock, SJ; Henderson, RA; Buxton, MJ; Fox, KAA |
| 2014 | Cost-effectiveness of the National Health Service abdominal aortic aneurysm screening programme in England | Glover, MJ; Kim, LG; Sweeting, MJ; Thompson, SG; Buxton, MJ |
| 1996 | Costs and cost effectiveness of cardiovascular screening and intervention: The British family heart study | Wonderling, D; McDermott, C; Buxton, MJ; Kinmonth, AL; Pyke, S; Thompson, S; Wood, D |
| 2012 | Current use and potential value of cost-effectiveness analysis in U.S. health care: The case of medicare national coverage determinations | Chambers, James |
| 2011 | The demand for sports and exercise: Results from an illustrative survey | Anokye, NK; Pokhrel, S; Buxton, MJ; Fox-Rushby, J |
| 2010 | Developing and applying a framework for assessing the payback from medical research | Hanney, S; Buxton, MJ |
| 2008 | Developing the protocol for the evaluation of the health foundation's 'engaging with quality initiative' – an emergent approach | Soper, B; Buxton, MJ; Hanney, S; Oortwijn, W; Scoggins, A; Steel, N; Ling, T |
| 1995 | Economic evaluation in intensive care: The case of SDD | Elliott, Rachel |
| 2008 | Economic evaluation of ASCOT-BPLA: Antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen | Lindgren, P; Buxton, MJ; Kahan, T; Poulter, NR; Dahlof, B; Sever, PS; Wedel, H; Jönsson, B |
| 2007 | Economic evaluation of ASCOT-BPLA: Antihypertensive treatment with an amlodipine-based regimen is cost-effective compared to an atenolol-based regimen | Lindgren, P; Buxton, MJ; Kahan, T; Poulter, NR; Dahlof, B; Sever, PS; Wedel, H; Jönsson, B |
| 2001 | Economic evaluation of health care technologies: A comparison of alternative decision modelling techniques | Karnon, Jonathan Daniel |
| 1996 | Economic evaluation of minimal access surgery: The case of surgical treatment for menorrhagia | Sculpher, Mark John |
| 1992 | Economic evaluation of ondansetron: Preliminary analysis using clinical trial data prior to price setting | Buxton, MJ; O'Brien, BJ |
